Entity Details

Primary name INGR2_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP38484
EntryNameINGR2_HUMAN
FullNameInterferon gamma receptor 2
TaxID9606
Evidenceevidence at protein level
Length337
SequenceStatuscomplete
DateCreated1994-10-01
DateModified2021-06-02

Ontological Relatives

GenesIFNGR2

GO terms

Show/Hide Table
GOName
GO:0000139 Golgi membrane
GO:0004896 cytokine receptor activity
GO:0004906 interferon-gamma receptor activity
GO:0005783 endoplasmic reticulum
GO:0005789 endoplasmic reticulum membrane
GO:0005886 plasma membrane
GO:0005887 integral component of plasma membrane
GO:0007166 cell surface receptor signaling pathway
GO:0009615 response to virus
GO:0016021 integral component of membrane
GO:0019221 cytokine-mediated signaling pathway
GO:0030659 cytoplasmic vesicle membrane
GO:0060333 interferon-gamma-mediated signaling pathway
GO:0060334 regulation of interferon-gamma-mediated signaling pathway

Subcellular Location

Show/Hide Table
Subcellular Location
Cell membrane
Cytoplasm
Cytoplasmic vesicle membrane
Endoplasmic reticulum membrane
Golgi apparatus membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR003961 Fibronectin type IIIDomainDomain
IPR013783 Immunoglobulin-like foldFamilyHomologous superfamily
IPR015373 Interferon/interleukin receptor domainDomainDomain
IPR036116 Fibronectin type III superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
614889 OMIMImmunodeficiency 28 (IMD28)A form of Mendelian susceptibility to mycobacterial disease, a rare condition caused by impairment of interferon-gamma mediated immunity. It is characterized by predisposition to illness caused by moderately virulent mycobacterial species, such as Bacillus Calmette-Guerin (BCG) vaccine, environmental non-tuberculous mycobacteria, and by the more virulent Mycobacterium tuberculosis. Other microorganisms rarely cause severe clinical disease in individuals with susceptibility to mycobacterial infections, with the exception of Salmonella which infects less than 50% of these individuals. Clinical outcome severity depends on the degree of impairment of interferon-gamma mediated immunity. Some patients die of overwhelming mycobacterial disease with lepromatous-like lesions in early childhood, whereas others develop, later in life, disseminated but curable infections with tuberculoid granulomas. IMD28 is an autosomal recessive disease that manifests early in life, with severe, often fatal, infection. The disease is caused by variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00033 Interferon gamma-1bDrugbankbiotech

Interactions

43 interactions

InteractorPartnerSourcesPublicationsLink
INGR2_HUMANKCC2D_HUMANBioGRID, IntAct21988832 details
INGR2_HUMANRL37A_HUMANBioGRID, IntAct21988832 details
INGR2_HUMANSFT2B_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANTM199_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANENTP3_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANPMP22_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANTREX1_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANTM254_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANTMM60_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANCD302_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANERMP1_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANCLC7A_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANTM140_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANTSN2_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANEMP3_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANBTNL8_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANDWORF_HUMANIntAct32296183 details
INGR2_HUMANS52A1_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANBRID5_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANSMIM3_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANUNC50_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANRTP2_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANTM218_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANGIMA5_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANT120B_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANSGMR2_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANBNIP3_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANPSPC_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANSC22B_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANCXCL9_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANJAGN1_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANZDH24_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANADIPO_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANINSI2_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANCLD19_HUMANBioGRID, IntAct32296183 details
INGR2_HUMANIFNG_HUMANBioGRID, HPRD7673114 details
INGR2_HUMANJAK2_HUMANBioGRID, HPRD7514165 7673114 details
INGR2_HUMANTARG1_HUMANBioGRID32296183 details
INGR2_HUMANANXA5_HUMANHPRD16670301 details
INGR2_HUMANKAP2_HUMANIntAct27621415 details
INGR2_HUMANDNJA3_HUMANBioGRID, HPRD11679576 details
INGR2_HUMANINGR1_HUMANHPRD7673114 details
INGR2_HUMANGCR_HUMANHPRD8349631 details